We use cookies to ensure that the website works as intended and to collect statistics on its use so that we can improve your web site experience.

×

Aker BioMarine introduces a new delivery platform for enhanced bioavailability of dietary supplement ingredients

This new disruptive technology platform, utilizing the true potential of phospholipids (PL’s), will help bring new products...

Aker BioMarine signs 18 strategic partnership agreements at China International Import Expo

Oslo, November 8, 2022: Aker BioMarine is onsite in Shanghai at China International Import Expo (CIIE) from November 5-10,...

Aker BioMarine strengthens QRILL™ Aqua sales team with new talent

(Oslo, September 6, 2022) Aker BioMarine is enhancing its QRILL™ Aqua sales organization after successfully recruiting two...

Aker BioMarine, CSIRO and Swisse winners of the 2022 Nutra Ingredients Asia Award

(Tuesday, September 6th, 2022) Aker BioMarine, CSIRO and Swisse took home this year’s Nutrition Research Project prize at...

First commercial agreement signed for Lysoveta

Oslo, 1 September 2022: Reference is made to the stock exchange release on 11 January 2021, with the announcement of the...

Aker BioMarine’s Patent Portfolio is Strengthened in the United States

(August 31, 2022) The United States Patent Trial and Appeal Board (PTAB) has rejected a challenge against Aker BioMarine’s...

Breakthrough study demonstrates positive effects of krill oil to improve osteoarthritis of the knee

Oslo, July, 27, 2022: A new study conducted by CSIRO, Australia’s national science agency, across three clinical trial sites...